Spreadsheet didn't work too well
Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7 Column 8 1 Assuming $920M FY18 2 Revenue$M 3 fy15 fy16 fy17 fy18 4 $H2 80.3 213.6 293.4 485.3 5 $H1 74.8 139.2 256.1 434.7 6 $FY 155.1 352.8 549.5 920 7 %age H2 to H1 growth 7.4 53.4 14.6 11.6
Column 1 Column 2 Column 3 Column 4 Column 5 1 YoY %age increase (growth) HY and FY 2 15 - 16 16 - 17 17 - 18 3 H2 166 37 65 4 H1 86 84 70 5 FY 127 56 67 6
Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7 Column 8 1 NPAT $M (920M example FY18 + $58M Mkt) 2 $H2 -2.2 20.23 51.2 94.7 3 $H1 0.1 10.17 39.4 98.5 4 $FY -2.1 30.4 90.6 193.2 5 %age H2 to H1 growth 98.9 29.9 -3.9
Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 1 YoY %age increase in NPAT (earnings) HY and FY 2 15 - 16 16 - 17 17 - 18 3 H2 -1020 153 85 4 H1 10070 287 150 5 FY -1548 198 113 6
- Forums
- ASX - By Stock
- A2M
- Chart Update
Chart Update, page-758
-
- There are more pages in this discussion • 24,473 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.85 |
Change
-0.030(0.44%) |
Mkt cap ! $4.952B |
Open | High | Low | Value | Volume |
$6.93 | $6.98 | $6.83 | $10.27M | 1.490M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 18844 | $6.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.85 | 41602 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 11039 | 6.840 |
1 | 3000 | 6.830 |
4 | 17920 | 6.820 |
4 | 9541 | 6.810 |
2 | 5020 | 6.800 |
Price($) | Vol. | No. |
---|---|---|
6.850 | 41602 | 1 |
6.860 | 548 | 1 |
6.870 | 8050 | 3 |
6.880 | 16820 | 3 |
6.890 | 5115 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online